Winter vacation period has just ended, also affected by covid-19 pandemic. Nevertheless, IASIS PHARMA stayed focused on its corporate responsibility, in order all employees return to their jobs safely. More specifically, before their return, all IASIS PHARMA employees were re-tested for covid-19. The tests were carried out by a well-established private clinic at IASIS PHARMA [...]
Webinar date: 3 - 6 /12/2020 COVID-19 pandemic has not only caused an unexpected global crisis, but also serious social and economic disruption. Consequently it has led worldwide, as well as in our country, to the postponement or cancellation of scientific events and seminars. However, some of them are held in the form of webinars. [...]
19-21/11/2020 Despite CoViD19 pandemic predicaments, IASIS PHARMA successfully participated in the 20th Panhellenic Hypertension Conference Webinar, organized by the Hellenic Hypertension Society (HHS), which took place on November 19-21, 2020. IASIS PHARMA supported the HHS effort, as there is an increasing number of adults in Greece having high blood pressure. At the same time, there [...]
Hellenic Gastroenterological Society Amphitheater, Athens, 6 - 7/11/2020 Despite Coronavirus pandemic predicament, IASIS PHARMA, with high sense of responsibility, successfully participated as a Gold Sponsor in the “25th Hellenic Conference of the Helicobacter Pylori & other Digestive Infections”. The conference was organized by the “Hellenic Society of Gastroenterology and the “Hellenic Society for Infectious Diseases” [...]
IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Sensibio® in 30 g. new package. Sensibio® 30 g. new package was launched to the market in order to complete Sensibio® 15 g., the well-established fixed combination of Fusidic acid (antibiotic) and [...]
IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Flusterix® in 30 g. new package. Flusterix® 30 g. was launched in order to complete the, well-established to the pharmaceutical market, Flusterix® 15 g. package. Flusterix® has Fusidic acid as its active ingredient, [...]
COVID-19 pandemic has caused an unprecedented, global health crisis. Moreover, one of the other numerous problems that COVID-19 has caused, is the lack of scientific events with physical appearance. Despite that, many scientific events are carried out online. One of these events was the Online Educational Workshop of the Professional Association of Greek Gastroenterologists (EP.E.G.E), [...]
IASIS PHARMA, compliant to its social corporate responsibility, after the free-of-charge production of 28.700lt of antiseptic solution for the Greek public health system, this time and in order all IASIS PHARMA employees to return to their jobs as safely as possible, carried out several pre-planned actions: - All IASIS PHARMA employees passed from covid-19 tests. [...]
For the extremely demanding pharmaceutical form of effervescent tablets, IASIS PHARMA chooses IMA technology, to combine top of the line quality with very high production capacity. IASIS PHARMA brand new pharma grade effervescent manufacturing facility is part of its second, 45.000m2 manufacturing site that became operational in 2019, in Koropi, Athens. The effervescent manufacturing facility is a [...]
Putting the emphasis on Authenticity. European Medicines Agency (EMA) recognized Chios Mastic as a medicine of herbal origin at the meeting that took place in London, on August 7 2015. The decision was unanimous and Chios Mastic was accepted to be included in the category of traditional herbal medicines. IASIS PHARMA played a pivotal role in the recognition of Chios Mastic both at European [...]
